Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 87 trials
NCI-2023-09270
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Adult (18-64)
Older adult (65+)
OCU200-101
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Adult (18-64)
Older adult (65+)
NCI-2022-07535
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Adult (18-64)
NRG-GI008
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Adult (18-64)
Older adult (65+)
NCI-2024-02361
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Adult (18-64)
Older adult (65+)
NCI-2024-07339
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Adult (18-64)
Older adult (65+)
NCI-2024-10081
Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
Adult (18-64)
Older adult (65+)
NCI-2021-09851
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Adult (18-64)
Older adult (65+)
A021806
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
Adult (18-64)
Older adult (65+)
LUNGMAP
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Adult (18-64)
Older adult (65+)